Part 3: What Actually Happens If Your NAV Loan Defaults?

Covenant triggers, lender remedies, and why the worst outcome is almost never the most likely one.

NAV Loan Default

Disclaimer: This article is illustrative and does not constitute legal or financial advice. The scenarios discussed build on the simplified models presented in Parts 1 and 2 of this series.

You can read Part 1 — Modelling LP Returns and Part 2 — Evaluating Stress Scenarios for the full model context.

From Models to Mechanics: Where Part 2 Left Off

In Part 1, we modelled a Growth GP using a $50M NAV facility (a loan secured against the fund’s net asset value, rather than individual portfolio companies) to double down on its breakout winner—Company 1, growing at 30% per annum. The facility was originated at a conservative 16.9% loan-to-value (LTV) against a portfolio NAV of $246.7M. In the base case, the NAV loan was clearly accretive: MOIC rose from 4.59x to 5.55x.

In Part 2, we stress-tested that thesis across four scenarios of increasing severity—from modest growth slowdowns through to catastrophic portfolio losses. We noted at the time that the models deliberately excluded the legal consequences of covenant triggers. This article fills that gap. Because, as the stress scenarios showed, even in Stress Level 2 (two portfolio companies bankrupt, the winner growing at just 8%), the fund still returned capital. The question GPs and LPs should be asking is not “what if the numbers go wrong?” but “what actually happens when they do?”

What “Default” Actually Means in NAV Lending

The word “default” conjures images of keys dropped on a bank manager’s desk. In fund finance, reality is far less dramatic. Most so-called defaults are technical covenant breaches—an LTV ratio that exceeds an agreed threshold, a concentration limit tripped after a mark-up in a single name, or a late quarterly valuation report. These are not failures to pay interest or principal.

Consider our model. The facility was originated at 16.9% LTV. A typical LTV covenant might sit at 2x the starting ratio—roughly 35%. In Part 2’s Stress Level 1, where Company 1’s growth slowed to 10% and the broader portfolio decelerated to 5%, the fund still produced a 2.69x MOIC with the NAV loan in place. LTV would have risen, potentially triggering a covenant, but the portfolio was far from impaired. That is the distinction: a covenant breach is an early warning system, not a death sentence.

NAV facilities are structured with graduated remedies precisely because both parties expect occasional covenant stress over a multi-year fund life. Cure periods of 60+ days are standard. Fund Finance Association survey data and practitioner reports from firms such as Cadwalader and Mayer Brown consistently note that negotiated resolutions vastly outnumber enforcement actions. Historical default rates in fund-level lending remain well below 1%—a figure that has held across multiple credit cycles.

Why Lenders Are Pragmatic, Not Predatory

We flagged this in Part 2: “NAV lenders don’t want to foreclose on a portfolio—they’d end up owning minority stakes in private companies they have no ability to manage.” That observation is worth unpacking, because it explains why enforcement is so rare in practice.

A NAV lender’s collateral is a diversified portfolio of illiquid, privately held assets—LP interests and portfolio company equity that cannot be sold on an exchange by close of business. Forcing a fire sale crystallises losses for the lender as much as for the borrower. The institutions active in this market like Nodem are repeat players who underwrite to fund-life timescales. Their business model depends on GP relationships across multiple funds. A lender that reaches for the nuclear option over a temporary valuation dip will find its pipeline drying up quickly.

This is also why the cash sweep mechanism in our model matters so much. As we showed in Part 1, the facility’s 25% sweep in Years 1–2 and 100% sweep from Year 3 amortises the loan through interim portfolio exits. That built-in deleveraging reduces the risk of a large balloon payment at maturity and gives the lender tangible evidence of repayment capacity—making forbearance a much easier conversation when it’s needed.

The Actual Playbook: What Happens Step by Step

Covenant breach is triggered. The lender issues formal notice and the cure period begins. During this window the borrower has several options: arranging additional capital contributions from the GP or LPs, making a partial prepayment to bring LTV back inside limits, adjusting portfolio composition, or providing updated third-party valuation support.

If the cure window closes without resolution, the parties negotiate. This is not a sudden escalation—it is a structured conversation. The borrower and lender enter forbearance discussions, and the range of outcomes is well-established:

Facility extension is the most common resolution—aligning the loan maturity with the fund’s wind-down timeline so that realisations can naturally service the debt. In our model, Company 1 was held to Year 10; a lender comfortable with that exit timeline has strong reason to extend rather than accelerate. Alternatively, the lender may agree to a temporary or permanent LTV covenant reset, typically in exchange for a margin step-up and enhanced reporting. A partial repayment funded by a secondary sale or single-asset exit is another common path. In some cases, the borrower may simply refinance with a different NAV lender on terms reflecting the portfolio’s current profile.

The nuclear option—full loan acceleration—is extremely rare. Even where acceleration rights exist on paper, remedies are typically limited to a pledge over fund distributions rather than forced asset sales. This is exactly the point we raised in Part 2: the lender does not want to own illiquid minority stakes. Acceleration is value-destructive for both sides, and experienced fund finance practitioners report it almost never occurs.

Applying This to the Part 2 Stress Scenarios

Revisiting our four scenarios through the lens of covenant mechanics makes the picture considerably less alarming:

Base Case and Stress Level 1 are unlikely to trigger meaningful covenant issues at all. Even in Stress Level 1—growth slowing materially across the portfolio—the fund still returned 2.69x MOIC with the NAV loan. LTV may drift toward covenant thresholds, but the cash sweep is working and realisations are occurring. A brief conversation with the lender, possibly a temporary waiver, and the facility runs to maturity.

Stress Level 2 (two companies bankrupt, winner growing at just 8%) is where covenants will almost certainly trigger. But the fund still returned 1.81x MOIC—capital was returned, exits happened, and the facility was substantially repaid through the sweep mechanism. This is a forbearance-and-extend scenario: the lender adjusts the LTV covenant, possibly steps up the margin, and allows the remaining portfolio to run off. The GP communicates transparently and both sides work toward an orderly conclusion.

Stress Level 3 (four of five companies bankrupt) is a near-total portfolio wipeout. The MOIC fell to 0.97x with the NAV loan—marginally below breakeven. This is the scenario where the lender’s recovery is genuinely impaired, and the conversation is most difficult. But even here, the remaining asset (Company 1, still growing at 8%) provides a recovery path. The practical outcome is likely an extended forbearance, with the lender taking distributions from the single surviving exit. It is worth emphasising: Stress Level 3 requires four simultaneous total losses. This is a tail risk scenario, not a base case.

The Key Takeaway

Across three articles, we have modelled the returns, stress-tested the downside, and now walked through the legal and practical mechanics of what happens when things go wrong. The conclusion is consistent: NAV loan defaults are manageable, not catastrophic. The architecture of these facilities—cure periods, cash sweeps, graduated remedies—is built for negotiation. Borrowers who communicate early, provide transparent reporting, and engage constructively with their lender will almost always find a workable path through a period of covenant stress.

The worst outcome is almost never the most likely outcome.

In NAV finance, the phone call you make to your lender at the first sign of trouble is worth more than any covenant cure period in the credit agreement.

Nodem Logo

London Office
Nodem Ltd

1a Britannia Street

London

United Kingdom

WC1X 9JT

Nodem Ltd is authorised and regulated by the Financial Conduct Authority, FRN 1017481. Nodem Ltd is registered in England and Wales under company number 15661530.


This website is for informational purposes only and does not constitute an offer, solicitation, or recommendation to sell or an offer to purchase any securities, investment products, or investment advisory services. This website and the information set forth herein are current as of 4 June 2025 and are not intended to provide investment recommendations or advice.

Nodem Logo

London Office
Nodem Ltd

1a Britannia Street

London

United Kingdom

WC1X 9JT

Nodem Ltd is authorised and regulated by the Financial Conduct Authority, FRN 1017481. Nodem Ltd is registered in England and Wales under company number 15661530.


This website is for informational purposes only and does not constitute an offer, solicitation, or recommendation to sell or an offer to purchase any securities, investment products, or investment advisory services. This website and the information set forth herein are current as of 4 June 2025 and are not intended to provide investment recommendations or advice.

London Office
Nodem Ltd

1a Britannia Street

London

United Kingdom

WC1X 9JT

Nodem Ltd is authorised and regulated by the Financial Conduct Authority, FRN 1017481. Nodem Ltd is registered in England and Wales under company number 15661530.


This website is for informational purposes only and does not constitute an offer, solicitation, or recommendation to sell or an offer to purchase any securities, investment products, or investment advisory services. This website and the information set forth herein are current as of 4 June 2025 and are not intended to provide investment recommendations or advice.

Nodem Logo

London Office
Nodem Ltd

1a Britannia Street

London

United Kingdom

WC1X 9JT

Nodem Ltd is authorised and regulated by the Financial Conduct Authority, FRN 1017481. Nodem Ltd is registered in England and Wales under company number 15661530.


This website is for informational purposes only and does not constitute an offer, solicitation, or recommendation to sell or an offer to purchase any securities, investment products, or investment advisory services. This website and the information set forth herein are current as of 4 June 2025 and are not intended to provide investment recommendations or advice.